Impact News +++ Why Is GoPro Stock Trading Higher Wednesday? (Benzinga) +++ GOPRO Aktie -5,39%

BOSTON SCIENTIFIC Aktie

>Aktienkurs

89.8 EUR +4.2% (Tradegate)

Ask: 90 EUR / 340 Stück

Bid: 89.8 EUR / 340 Stück

Tagesumsatz: 4086 Stück

Realtime Kurs von 7:30 bis 22 Uhr!

Aktie über LYNX handeln

Intraday

1 Jahr

>Performance

1 Woche: +3,9%

1 Monat: +3,4%

3 Monate: -3,4%

6 Monate: +2,9%

1 Jahr: +4,9%

laufendes Jahr: -1,1%

>BOSTON SCIENTIFIC Aktie

Name:

BOSTON SCIENTIFIC DL-,01

Land:

USA

Sektor:

Gesundheit

ISIN/ Wkn:

US1011371077 / 884113

Symbol/ Ticker:

BSX (Frankfurt) / BSX (NYSE)

Kürzel:

FRA:BSX, ETR:BSX, BSX:GR, NYSE:BSX

Index:

S&P500

Webseite:

http://www.bostonscientif..

Profil:

Boston Scientific Corporation, a leading global me..
>Volltext..

Marktkapitalisierung:

128264.94 Mio. EUR

Unternehmenswert:

138153.49 Mio. EUR

Umsatz:

15924.57 Mio. EUR

EBITDA:

3786.11 Mio. EUR

Nettogewinn:

2157.83 Mio. EUR

Gewinn je Aktie:

1.46 EUR

Schulden:

10356.05 Mio. EUR

Liquide Mittel:

553.67 Mio. EUR

Operativer Cashflow:

3689.67 Mio. EUR

Bargeldquote:

0.12

Umsatzwachstum:

10.43%

Gewinnwachstum:

24.79%

Dividende je Aktie:

Dividendenrendite:

Dividendenschätzung:

Insiderhandel:

1 Insider verkaufte innerhalb der letzten 30 Tage Aktien im Wert von 4.923.326 USD.

Suchwörter:

BOSTON SCIENTIFIC

Letzte Datenerhebung:

22.10.25

>Kennzahlen

Aktien/ Unternehmen:

Aktien: 1481.75 Mio. St.

Frei handelbar: 99.59%

Leerverk. Aktien: 1.31%

Rückkaufquote: -0.18%

Mitarbeiter: 53000

Umsatz/Mitarb.: 0.27 Mio. EUR

Analysten:

Analystenrating: Strong buy

Kursziel: 26.91%

Bewertung:

KGV: 59.73

KGV lG: 33.29

KUV: 8.05

KBV: 6.63

PEG-Ratio: 1.65

EV/EBITDA: 36.49

Rentabilität:

Bruttomarge: 61.9%

Gewinnmarge: 13.55%

Operative Marge: 16.66%

Managementeffizenz:

Gesamtkaprendite: 6.37%

Eigenkaprendite: 11.71%

>Anleihen

Es sind 1 Anleihen zur BOSTON SCIENTIFIC Aktie bekannt.

>Peer Group

Es sind 597 Aktien bekannt.

>Chart & Kurs - NYSE

>Alle News

22.10.25 - 16:45	Boston Scientific Beats on Q3 Earnings, Raises 2025 View, Stock Up (Zacks)
	BSX posts strong Q3 with 19% EPS growth, lifts 2025 sales and EPS outlook as shares edge higher....

22.10.25 - 16:45	Boston Scientific (BSX) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates (Zacks)
	Although the revenue and EPS for Boston Scientific (BSX) give a sense of how its business performed in the quarter ended September 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers....

22.10.25 - 15:43	Boston Scientific übertrifft Prognosen für Q3 2025 – Aktie legt zu (Investing.com DE)
	Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...

22.10.25 - 15:15	Boston Scientific (BSX) Q3 Earnings and Revenues Top Estimates (Zacks)
	Boston Scientific (BSX) delivered earnings and revenue surprises of +5.63% and +1.94%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?...

22.10.25 - 13:21	Earnings Snapshot: Boston Scientific tops Q3 estimates; initiates Q4 and updates FY outlook above forecast (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

22.10.25 - 13:01	Boston Scientific Corp Q3 Profit Increases, Beats Estimates (AFX)
	WASHINGTON (dpa-AFX) - Boston Scientific Corp (BSX) released a profit for its third quarter that Increased from last year and beat the Street estimates.The company's bottom line totaled $755 milli......

22.10.25 - 13:00	Boston Scientific Raises Outlook on Continued Cardiovascular Growth (WSJ EN)
	The medical device company recorded higher third-quarter sales and raised its full-year earnings guidance on the back of continued growth in its cardiovascular segment....

22.10.25 - 12:39	Boston Scientific Non-GAAP EPS of $0.75 beats by $0.04, revenue of $5.07B beats by $100M (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

22.10.25 - 12:33	Boston Scientific announces results for third quarter 2025 (PR Newswire)
	MARLBOROUGH, Mass., Oct. 22, 2025 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) generated net sales of $5.065 billion during the third quarter of 2025, growing 20.3 percent on a reported basis, 19.4 percent on an operational1 basis and 15.3 percent on an organic2 basis, all......

21.10.25 - 17:42	Boston Scientific Q3 2025 Earnings Preview (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

18.10.25 - 01:15	21 Analysts Have This To Say About Boston Scientific (Benzinga)
	Latest Ratings for BSX DateFirmActionFromTo Feb 2022Morgan StanleyMaintainsOverweight Feb 2022Raymond JamesMaintainsStrong Buy Feb 2022SVB LeerinkMaintainsMarket Perform View More Analyst Ratings for BSX View the Latest Analyst Ratings read more...

17.10.25 - 16:45	Unlocking Q3 Potential of Boston Scientific (BSX): Exploring Wall Street Estimates for Key Metrics (Zacks)
	Besides Wall Street's top-and-bottom-line estimates for Boston Scientific (BSX), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended September 2025....

17.10.25 - 14:12	Boston Scientific To Buy Nalu Medical For Upfront $533 Mln Cash (AFX)
	WASHINGTON (dpa-AFX) - Boston Scientific Corporation (BSX), a medical technology company, said on Friday that it has inked a deal to acquire Nalu Medical, Inc., a privately held medical technology......

17.10.25 - 13:21	Boston Scientific to acquire Nalu Medical in $533M deal (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

17.10.25 - 13:03	Boston Scientific Announces Agreement to Acquire Nalu Medical, Inc. (PR Newswire)
	Acquisition to expand the neuromodulation offerings for people living with chronic pain MARLBOROUGH, Mass., Oct. 17, 2025 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced it has entered into a definitive agreement to acquire Nalu Medical, Inc., a privately held......

15.10.25 - 17:30	Boston Scientific (BSX) Reports Next Week: Wall Street Expects Earnings Growth (Zacks)
	Boston Scientific (BSX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations....

11.10.25 - 01:45	Boston Scientific (BSX) Stock Moves -1.92%: What You Should Know (Zacks)
	In the most recent trading session, Boston Scientific (BSX) closed at $95.41, indicating a -1.92% shift from the previous trading day....

06.10.25 - 17:30	Why Boston Scientific (BSX) is a Top Growth Stock for the Long-Term (Zacks)
	The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage....

06.10.25 - 16:18	What You Need To Know Ahead of Boston Scientifics Earnings Release (Barchart)
	Boston Scientific is poised to release its third-quarter results later this month, and analysts project a double-digit earnings growth....

03.10.25 - 13:00	The Zacks Analyst Blog Highlights Boston Scientific, Union Pacific, Realty Income and Weyco (Zacks)
	BSX, UNP, O, and WEYS stand out with strong sector performance, resilient cash flows, and strategic growth moves, despite headwinds from tariffs, e-commerce, and macro uncertainties....

>weitere News anzeigen...

>Impressum >Über uns >Datenschutz >Financial Data & Solutions

>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!

Zitat des Tages: Wer auf jede Feder siehet, wird langsam ein Bette zusammenbringen. - Sprichwort Deutschland

Partner: >Tradegate Börse | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook |

Börsentreff auf X |

Börsentreff auf Instagram